The Colombian government is set to issue a decree that would, for the first time, allow the legal sale of medicinal cannabis flower in pharmacies with a medical prescription—a historic move that could expand domestic access and support small-scale growers.
Current legal framework for medical cannabis in Colombia
Evolution since Law 1787 of 2016, which regulated derivatives for medical purposes.
Expansion in 2021 for industrial production and exports.
The new decree: sale in pharmacies with a prescription
- The sale of cannabis flowers with a prescription would be allowed to treat chronic pain, insomnia, and neurological disorders.
- For two years, only micro, small, and medium-sized producers would be authorized to supply the domestic market.
- Products with THC greater than 1% would be considered special control medications.
Impact and challenges of the new regulatory framework
- Improving national access by reducing dependence on expensive imports.
canamo.net - Opportunity for small producers to formally enter the market.
Transnational Institute. - Necessary consolidation of sanitary controls and medical monitoring.
In summary, this decree would mark a major shift in Colombia’s medical cannabis policy, prioritizing public health and empowering a local industry. What do you think about this initiative? Leave your comment and share this article if you believe it could inform more people.
English 
Spanish